Polymorphonuclear neutrophil response to Burkholderia pseudomallei in patients with diabetes mellitus

Background and objectives: Burkholderia pseudomallei is the causative agent of melioidosis, a potentially fatal disease endemic in Bangladesh. Diabetes mellitus (DM) is a risk factor for increased susceptibility to B. pseudomallei infection. A few studies have been conducted to identify the underlyi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:IMC journal of medical science (Online) 2020-02, Vol.13 (2), p.28-34
Hauptverfasser: Mazumder, Sraboni, Barai, Lovely, Jilani, Md Shariful Alam, Islam, KM Shahidul, Haq, Jalaluddin Ashraful
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 34
container_issue 2
container_start_page 28
container_title IMC journal of medical science (Online)
container_volume 13
creator Mazumder, Sraboni
Barai, Lovely
Jilani, Md Shariful Alam
Islam, KM Shahidul
Haq, Jalaluddin Ashraful
description Background and objectives: Burkholderia pseudomallei is the causative agent of melioidosis, a potentially fatal disease endemic in Bangladesh. Diabetes mellitus (DM) is a risk factor for increased susceptibility to B. pseudomallei infection. A few studies have been conducted to identify the underlying immunological mechanism responsible for increased susceptibility of individuals with diabetes mellitus to B. pseudomallei infection. The present study investigated the polymorphonuclear neutrophil (PMN) response to B. pseudomallei in terms of phagocytosis and early respiratory burst in individuals with diabetes mellitus. Materials and Methods: A total of 5 cases of DM and 5 age and sex matched non-diabetic healthy individuals were enrolled in the study to determine the early respiratory burst and phagocytic ability of PMN to B. pseudomallei. The effect of B. pseudomallei on phagocytic ability and early respiratory burst of PMN was determined by phagocytic assay and nitroblue tetrazolium (NBT) test respectively. The response of PMN treated with B. pseudomallei was compared with that of Escherichia coli. Results: There was no significant (p>0.05) difference in phagocytosis of B. pseudomallei by PMN between diabetic and non-diabetic cases (21.8±4.64 percent vs 29.25±5.5 percent). But in both diabetic and non-diabetic cases, significantly (p˂0.05 and p˂0.01) reduced rate of phagocytosis of B. pseudomallei by PMN was observed compared to E. coli (21.8±4.64 vs 65±5.36; 29.25±5.5 vs 71.25±5.59). Similar results were obtained in terms of phagocytic index. Mean percentage of formazan positive PMN from diabetic cases was not significantly different (p>0.05) from non-diabetic healthy cases when cells were treated with B. pseudomallei or E. coli. In both diabetic and healthy individuals, mean percentage of formazan positive PMN treated by B. pseudomallei was not significantly different from that by E. coli. Conclusion: The observations revealed that B. pseudomallei was equally capable of inhibiting the phagocytic ability of PMN from both diabetic and non-diabetic individuals. This anti-phagocytic property might play an important role in the pathogenesis of melioidosis. Ibrahim Med. Coll. J. 2019; 13(2): 28-34
doi_str_mv 10.3329/imcjms.v13i2.45278
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_3329_imcjms_v13i2_45278</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_3329_imcjms_v13i2_45278</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_3329_imcjms_v13i2_452783</originalsourceid><addsrcrecordid>eNqdz0tOAzEQBFALgZQIcoGs-gIZxp5MPlsQiCUL9paZ6Wg6-KduG5TbAwEuwKpKJdXiKbXUbdN1Zn9LYTgGad51R6ZZ92a7u1Bz0-v9Sve7zeVf3xo9UwuRY9u2xqw3X8Nc4XPyp5A4TynWwaNjiFgLpzyRB0bJKQpCSXBX-W1KfkQmB1mwjik475GAImRXCGMR-KAywUjuFQsKBPSeSpUbdXVwXnDxm9fKPD683D-tBk4ijAebmYLjk9Wt_TbZH5M9m-zZ1P3r9AmMPFwJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Polymorphonuclear neutrophil response to Burkholderia pseudomallei in patients with diabetes mellitus</title><source>DOAJ Directory of Open Access Journals</source><creator>Mazumder, Sraboni ; Barai, Lovely ; Jilani, Md Shariful Alam ; Islam, KM Shahidul ; Haq, Jalaluddin Ashraful</creator><creatorcontrib>Mazumder, Sraboni ; Barai, Lovely ; Jilani, Md Shariful Alam ; Islam, KM Shahidul ; Haq, Jalaluddin Ashraful</creatorcontrib><description>Background and objectives: Burkholderia pseudomallei is the causative agent of melioidosis, a potentially fatal disease endemic in Bangladesh. Diabetes mellitus (DM) is a risk factor for increased susceptibility to B. pseudomallei infection. A few studies have been conducted to identify the underlying immunological mechanism responsible for increased susceptibility of individuals with diabetes mellitus to B. pseudomallei infection. The present study investigated the polymorphonuclear neutrophil (PMN) response to B. pseudomallei in terms of phagocytosis and early respiratory burst in individuals with diabetes mellitus. Materials and Methods: A total of 5 cases of DM and 5 age and sex matched non-diabetic healthy individuals were enrolled in the study to determine the early respiratory burst and phagocytic ability of PMN to B. pseudomallei. The effect of B. pseudomallei on phagocytic ability and early respiratory burst of PMN was determined by phagocytic assay and nitroblue tetrazolium (NBT) test respectively. The response of PMN treated with B. pseudomallei was compared with that of Escherichia coli. Results: There was no significant (p&gt;0.05) difference in phagocytosis of B. pseudomallei by PMN between diabetic and non-diabetic cases (21.8±4.64 percent vs 29.25±5.5 percent). But in both diabetic and non-diabetic cases, significantly (p˂0.05 and p˂0.01) reduced rate of phagocytosis of B. pseudomallei by PMN was observed compared to E. coli (21.8±4.64 vs 65±5.36; 29.25±5.5 vs 71.25±5.59). Similar results were obtained in terms of phagocytic index. Mean percentage of formazan positive PMN from diabetic cases was not significantly different (p&gt;0.05) from non-diabetic healthy cases when cells were treated with B. pseudomallei or E. coli. In both diabetic and healthy individuals, mean percentage of formazan positive PMN treated by B. pseudomallei was not significantly different from that by E. coli. Conclusion: The observations revealed that B. pseudomallei was equally capable of inhibiting the phagocytic ability of PMN from both diabetic and non-diabetic individuals. This anti-phagocytic property might play an important role in the pathogenesis of melioidosis. Ibrahim Med. Coll. J. 2019; 13(2): 28-34</description><identifier>ISSN: 2519-1721</identifier><identifier>EISSN: 2519-1586</identifier><identifier>DOI: 10.3329/imcjms.v13i2.45278</identifier><language>eng</language><ispartof>IMC journal of medical science (Online), 2020-02, Vol.13 (2), p.28-34</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,866,27931,27932</link.rule.ids></links><search><creatorcontrib>Mazumder, Sraboni</creatorcontrib><creatorcontrib>Barai, Lovely</creatorcontrib><creatorcontrib>Jilani, Md Shariful Alam</creatorcontrib><creatorcontrib>Islam, KM Shahidul</creatorcontrib><creatorcontrib>Haq, Jalaluddin Ashraful</creatorcontrib><title>Polymorphonuclear neutrophil response to Burkholderia pseudomallei in patients with diabetes mellitus</title><title>IMC journal of medical science (Online)</title><description>Background and objectives: Burkholderia pseudomallei is the causative agent of melioidosis, a potentially fatal disease endemic in Bangladesh. Diabetes mellitus (DM) is a risk factor for increased susceptibility to B. pseudomallei infection. A few studies have been conducted to identify the underlying immunological mechanism responsible for increased susceptibility of individuals with diabetes mellitus to B. pseudomallei infection. The present study investigated the polymorphonuclear neutrophil (PMN) response to B. pseudomallei in terms of phagocytosis and early respiratory burst in individuals with diabetes mellitus. Materials and Methods: A total of 5 cases of DM and 5 age and sex matched non-diabetic healthy individuals were enrolled in the study to determine the early respiratory burst and phagocytic ability of PMN to B. pseudomallei. The effect of B. pseudomallei on phagocytic ability and early respiratory burst of PMN was determined by phagocytic assay and nitroblue tetrazolium (NBT) test respectively. The response of PMN treated with B. pseudomallei was compared with that of Escherichia coli. Results: There was no significant (p&gt;0.05) difference in phagocytosis of B. pseudomallei by PMN between diabetic and non-diabetic cases (21.8±4.64 percent vs 29.25±5.5 percent). But in both diabetic and non-diabetic cases, significantly (p˂0.05 and p˂0.01) reduced rate of phagocytosis of B. pseudomallei by PMN was observed compared to E. coli (21.8±4.64 vs 65±5.36; 29.25±5.5 vs 71.25±5.59). Similar results were obtained in terms of phagocytic index. Mean percentage of formazan positive PMN from diabetic cases was not significantly different (p&gt;0.05) from non-diabetic healthy cases when cells were treated with B. pseudomallei or E. coli. In both diabetic and healthy individuals, mean percentage of formazan positive PMN treated by B. pseudomallei was not significantly different from that by E. coli. Conclusion: The observations revealed that B. pseudomallei was equally capable of inhibiting the phagocytic ability of PMN from both diabetic and non-diabetic individuals. This anti-phagocytic property might play an important role in the pathogenesis of melioidosis. Ibrahim Med. Coll. J. 2019; 13(2): 28-34</description><issn>2519-1721</issn><issn>2519-1586</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqdz0tOAzEQBFALgZQIcoGs-gIZxp5MPlsQiCUL9paZ6Wg6-KduG5TbAwEuwKpKJdXiKbXUbdN1Zn9LYTgGad51R6ZZ92a7u1Bz0-v9Sve7zeVf3xo9UwuRY9u2xqw3X8Nc4XPyp5A4TynWwaNjiFgLpzyRB0bJKQpCSXBX-W1KfkQmB1mwjik475GAImRXCGMR-KAywUjuFQsKBPSeSpUbdXVwXnDxm9fKPD683D-tBk4ijAebmYLjk9Wt_TbZH5M9m-zZ1P3r9AmMPFwJ</recordid><startdate>20200203</startdate><enddate>20200203</enddate><creator>Mazumder, Sraboni</creator><creator>Barai, Lovely</creator><creator>Jilani, Md Shariful Alam</creator><creator>Islam, KM Shahidul</creator><creator>Haq, Jalaluddin Ashraful</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20200203</creationdate><title>Polymorphonuclear neutrophil response to Burkholderia pseudomallei in patients with diabetes mellitus</title><author>Mazumder, Sraboni ; Barai, Lovely ; Jilani, Md Shariful Alam ; Islam, KM Shahidul ; Haq, Jalaluddin Ashraful</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_3329_imcjms_v13i2_452783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mazumder, Sraboni</creatorcontrib><creatorcontrib>Barai, Lovely</creatorcontrib><creatorcontrib>Jilani, Md Shariful Alam</creatorcontrib><creatorcontrib>Islam, KM Shahidul</creatorcontrib><creatorcontrib>Haq, Jalaluddin Ashraful</creatorcontrib><collection>CrossRef</collection><jtitle>IMC journal of medical science (Online)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mazumder, Sraboni</au><au>Barai, Lovely</au><au>Jilani, Md Shariful Alam</au><au>Islam, KM Shahidul</au><au>Haq, Jalaluddin Ashraful</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Polymorphonuclear neutrophil response to Burkholderia pseudomallei in patients with diabetes mellitus</atitle><jtitle>IMC journal of medical science (Online)</jtitle><date>2020-02-03</date><risdate>2020</risdate><volume>13</volume><issue>2</issue><spage>28</spage><epage>34</epage><pages>28-34</pages><issn>2519-1721</issn><eissn>2519-1586</eissn><abstract>Background and objectives: Burkholderia pseudomallei is the causative agent of melioidosis, a potentially fatal disease endemic in Bangladesh. Diabetes mellitus (DM) is a risk factor for increased susceptibility to B. pseudomallei infection. A few studies have been conducted to identify the underlying immunological mechanism responsible for increased susceptibility of individuals with diabetes mellitus to B. pseudomallei infection. The present study investigated the polymorphonuclear neutrophil (PMN) response to B. pseudomallei in terms of phagocytosis and early respiratory burst in individuals with diabetes mellitus. Materials and Methods: A total of 5 cases of DM and 5 age and sex matched non-diabetic healthy individuals were enrolled in the study to determine the early respiratory burst and phagocytic ability of PMN to B. pseudomallei. The effect of B. pseudomallei on phagocytic ability and early respiratory burst of PMN was determined by phagocytic assay and nitroblue tetrazolium (NBT) test respectively. The response of PMN treated with B. pseudomallei was compared with that of Escherichia coli. Results: There was no significant (p&gt;0.05) difference in phagocytosis of B. pseudomallei by PMN between diabetic and non-diabetic cases (21.8±4.64 percent vs 29.25±5.5 percent). But in both diabetic and non-diabetic cases, significantly (p˂0.05 and p˂0.01) reduced rate of phagocytosis of B. pseudomallei by PMN was observed compared to E. coli (21.8±4.64 vs 65±5.36; 29.25±5.5 vs 71.25±5.59). Similar results were obtained in terms of phagocytic index. Mean percentage of formazan positive PMN from diabetic cases was not significantly different (p&gt;0.05) from non-diabetic healthy cases when cells were treated with B. pseudomallei or E. coli. In both diabetic and healthy individuals, mean percentage of formazan positive PMN treated by B. pseudomallei was not significantly different from that by E. coli. Conclusion: The observations revealed that B. pseudomallei was equally capable of inhibiting the phagocytic ability of PMN from both diabetic and non-diabetic individuals. This anti-phagocytic property might play an important role in the pathogenesis of melioidosis. Ibrahim Med. Coll. J. 2019; 13(2): 28-34</abstract><doi>10.3329/imcjms.v13i2.45278</doi></addata></record>
fulltext fulltext
identifier ISSN: 2519-1721
ispartof IMC journal of medical science (Online), 2020-02, Vol.13 (2), p.28-34
issn 2519-1721
2519-1586
language eng
recordid cdi_crossref_primary_10_3329_imcjms_v13i2_45278
source DOAJ Directory of Open Access Journals
title Polymorphonuclear neutrophil response to Burkholderia pseudomallei in patients with diabetes mellitus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T13%3A43%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Polymorphonuclear%20neutrophil%20response%20to%20Burkholderia%20pseudomallei%20in%20patients%20with%20diabetes%20mellitus&rft.jtitle=IMC%20journal%20of%20medical%20science%20(Online)&rft.au=Mazumder,%20Sraboni&rft.date=2020-02-03&rft.volume=13&rft.issue=2&rft.spage=28&rft.epage=34&rft.pages=28-34&rft.issn=2519-1721&rft.eissn=2519-1586&rft_id=info:doi/10.3329/imcjms.v13i2.45278&rft_dat=%3Ccrossref%3E10_3329_imcjms_v13i2_45278%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true